Drug Type Small molecule drug |
Synonyms AZD 8329, AZD8329 |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H31N3O3 |
InChIKeyXWBXJBSVYVJAMZ-UHFFFAOYSA-N |
CAS Registry1048668-70-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | United Kingdom | 01 Nov 2010 | |
Obesity | Phase 1 | United Kingdom | 01 Sep 2010 |